CRISPR

Approvals News

FDA Expands Casgevy Approval for Children as Young as 2 With Sickle Cell Disease
Life Science News

How New FDA Guidance Could Help Speed Cell and Gene Therapy Development

Simplifying CRISPR Therapeutic Manufacturing: Practical Solutions to Accelerate and Simplify Manufacturing

October 27, 2025

High-Titer Lentivirus Solutions in 5 Days: Break Production Barriers for CGT

September 04, 2025

How Cell-Free mRNA Templates Support Faster Research with High-Quality and Quick Turnaround

August 22, 2025
Biotech Blogs

Top 15 Most Innovative Pharma & Biotech Companies of 2025, According to Fast Company

Unlocking the Future of Gene Editing: Key Concepts and Breakthroughs in CRISPR

May 09, 2025
Biotech Blogs

Top 10 Biotech Trends for 2025
Blogs

Best Pharma Innovations of 2024, According to TIME

Unlocking CRISPR: Advances in Base Editing, Prime Editing and Future Applications

October 30, 2024

Boost CRISPR Editing Efficiency Using Optimized sgRNA and HDR Template Design

October 08, 2024
Life Science Podcast

Gene Editing Innovations with Programmable Gene Insertion (PGI) Technology ft. John Finn, PhD, CSO, Tome Biosciences – Xtalks Life Science Podcast Ep. 160
Blogs

Rare Disease Day 2024: Highlighting Patient Stories and Advancements in Rare Disease Research – Xtalks Life Science Podcast Ep. 148
Blogs

Life Science Trends for 2024 – Xtalks Life Science Podcast Ep. 143
Blogs

Life Science Trends to Look Out for in 2024
Biotech News

Exa-Cel CRISPR Gene Therapy for Sickle Cell Disease Deemed Safe by FDA Advisory Panel